Director, Clinical Pharmacology

Overview The Clinical Pharmacology (CP), Director role will effectively provide expertise and support for the design, execution, interpretation and reporting of clinical pharmacokinetic/pharmacodynamic (PK/PD) studies. This individual will participate in the selection of Phase 1 CROs for clinical pharmacology studies. Individual will be functional CP Lead and will ensure that the preclinical characterization is adequate and provides support in characterizing the clinical pharmacology profile of a given compound. CP Lead will also ensure that the CP strategy/plans fully support the selection of dose(s) and regimen for Phase 1, 2 and 3 studies. Individual will serve as CP representative on studies and project teams, and will contribute to the planning, writing, implementation and organization of regulatory filings along with presentation of PK/PD data to internal cross‑functional teams and external collaborators. The Clinical Pharmacology, Director may provide oversight and be responsible for the pharmacometric related analyses and activities in support of the clinical pharmacology profile of a compound. The Director may also serve as a mentor to less experienced staff and as a Clinical Pharmacology resource within the function and across the company eg in matters related to due diligence. Responsibilities Act as Clinical Pharmacology representative providing clinical pharmacology expertise to multidisciplinary study teams for one or more early and late‑stage clinical and lifecycle management projects/programs Provide support in the designing and interpreting of Phase 1 as well as other clinical studies/clinical programs that have PK or PK/PD data Perform or supervise non‑compartmental analysis of PK data and ensuring appropriate PK‑PD analysis including population PK or PK/PD modeling and simulation analyses Contribute to appropriate design of clinical study protocols and review of clinical study reports Contribute to the selection of Phase 1 CROs Participate in dose selection for Phase 1 as well as for Phase 2 and 3 clinical studies Work closely with preclinical/nonclinical, biostatisticians, clinical operations colleagues, medical directors, and regulatory affairs personnel within SKLSI as well as in SKBP for the timely completion of clinical studies and regulatory filings Represent the Clinical Pharmacology group on multi‑disciplinary study/project teams Responsible for and contribute CP related components to regulatory documents (INDs, NDAs, and IBs) as needed Act as the Clinical Study Lead for all Clinical Pharmacology/Phase 1 studies Qualifications Education Preferred: PharmD or PhD degree in Pharmaceutical Sciences or related discipline will be considered Work Experience: At least 7+ years of industry experience and a proven track record within the duties mentioned above with a background in PK and PD, Biopharmaceutics and Pharmacometrics Previous experience in leading clinical pharmacology programs Experience in oncology preferred including a strong understanding of clinical trial design and regulatory requirements Preferably a working knowledge of NONMEM and R or other commensurate software utilized in Pharmacometric analyses Excellent writing and verbal communication skills Ability to work in a matrix environment and with different leadership styles Work independently, proactively and effectively All qualified applicants will receive consideration for employment without regard to race, color, religion, sex, sexual orientation, gender identity, national origin, disability, or status as a protected veteran. #J-18808-Ljbffr